Approximately 65% of Women in the United States Are Using Contraceptives
Almost two-thirds of U.S. women aged 15 to 49 years were currently using contraception in 2015 to 2017.
Contraception
Five-Year Efficacy Data Announced for Liletta Intrauterine System
Phase 3 trial results assessing the intrauterine system, Liletta (levonorgestrel 52 mg), found that it had >99% efficacy in preventing pregnancy for up to 5 years; the products current Food and Drug Administration indication.
Medicaid Expansion Programs Improve Women’s Access to Reproductive Services
One-third of the women enrolled in Michigan’s Medicaid expansion program reported improved access to birth control and family planning services.
Newer Hormonal Contraception May Reduce Ovarian Cancer Risk
There is a reduction in ovarian cancer risk associated with use of contemporary combined hormonal contraceptives.
Oral Contraceptives Associated With Ventricular Repolarization Alterations
Healthy nonmenopausal women taking oral contraceptives exhibited biomarkers for drug-induced torsade de pointes.
FDA Approves First Mobile App for Use in Preventing Pregnancy
The algorithm was designed to account for sperm survival, variation in cycle length, ovulation day, temperature fluctuations and the length of the follicular and luteal phases of the menstrual cycle.
Self-Administered Contraceptive Vaginal System Approved for Up to 1 Year of Use
The safety and efficacy of Annovera was evaluated in 3 open-label clinical trials involving healthy women (ages 18 to 40).
Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Unplanned Pregnancies Prevalent Among HIV-Positive Women
Researchers examined unplanned pregnancies and contraceptive use among HIV-positive women in a cross-sectional study.
Injectable Progestin-Only Contraceptives May Increase Risk for VTE
Investigators examined the effect of progestin-only contraceptive on cardiometabolic outcomes, including stroke, MI, hypertension, diabetes, and VTE.
Next post in General Endocrinology
